Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management.
作者信息
Chiu Yu-Wei, Wu Yen-Wen
机构信息
Cardiology Division of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City.
Department of Computer Science and Engineering, Yuan Ze University, Taoyuan.
出版信息
Acta Cardiol Sin. 2023 Mar;39(2):209-212. doi: 10.6515/ACS.202303_39(2).20230208A.
Abstract
摘要
相似文献
1
Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management.肺动脉高压：一种需多学科团队管理的进展性疾病
Acta Cardiol Sin. 2023 Mar;39(2):209-212. doi: 10.6515/ACS.202303_39(2).20230208A.
2
The role of a multidisciplinary team in a pediatric pulmonary hypertension center.多学科团队在儿科肺动脉高压中心的作用。
Pediatr Pulmonol. 2021 Mar;56(3):630-635. doi: 10.1002/ppul.24761. Epub 2020 Apr 6.
3
Programmed Follow-up and Quality Control of Treatment Techniques Enhance Chronic Thromboembolic Pulmonary Hypertension Management: Lessons From a Multidisciplinary Team.治疗技术的程序化随访与质量控制可加强慢性血栓栓塞性肺动脉高压的管理：来自多学科团队的经验教训
Korean Circ J. 2024 Jul;54(7):409-421. doi: 10.4070/kcj.2024.0021. Epub 2024 Jun 3.
4
Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team.多学科团队治疗慢性血栓栓塞性肺动脉高压。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619891529. doi: 10.1177/1753466619891529.
5
The effect of a multidisciplinary team on the implementation rates of major diagnostic and therapeutic procedures of chronic thromboembolic pulmonary hypertension.多学科团队对慢性血栓栓塞性肺动脉高压主要诊断和治疗程序实施率的影响。
Heart Lung. 2019 Jan;48(1):28-33. doi: 10.1016/j.hrtlng.2018.07.008. Epub 2018 Aug 14.
6
[Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre].[系统性硬化症患者肺动脉高压的筛查：在一个专科中心，将DETECT算法与多学科团队的诊断结果进行比较]
Rev Med Interne. 2017 Aug;38(8):502-507. doi: 10.1016/j.revmed.2017.04.005. Epub 2017 May 22.
7
Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease.多学科团队讨论：结缔组织疾病心肺并发症管理的新兴金标准。
Intern Med J. 2023 Oct;53(10):1919-1924. doi: 10.1111/imj.16233. Epub 2023 Sep 29.
8
Emergencies in Pulmonary Hypertension.肺动脉高压急症。
Cardiol Clin. 2024 May;42(2):273-278. doi: 10.1016/j.ccl.2024.02.011. Epub 2024 Mar 23.
9
Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications.改善肺动脉高压药物治疗的危重症成年患者的转归。
Am J Health Syst Pharm. 2020 Jun 4;77(12):958-965. doi: 10.1093/ajhp/zxaa079.
10
Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients - An Ongoing Approach.肺动脉高压患者失代偿性右心衰竭的重症监护管理——一种持续的方法。
J Crit Care Med (Targu Mures). 2021 Aug 5;7(3):170-183. doi: 10.2478/jccm-2021-0020. eCollection 2021 Jul.
引用本文的文献
1
An exceptional case of coronary artery collateralization in unilateral pulmonary artery agenesis: implications for right heart failure in the elderly.单侧肺动脉缺如时冠状动脉侧支循环的一个特殊病例：对老年右心衰竭的影响
J Geriatr Cardiol. 2025 May 28;22(6):600-602. doi: 10.26599/1671-5411.2025.06.008.
本文引用的文献
1
2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.2023年台湾心脏病学会（TSOC）与台湾风湿病学会（TCR）关于结缔组织病相关肺动脉高压的联合共识
Acta Cardiol Sin. 2023 Mar;39(2):213-241. doi: 10.6515/ACS.202303_39(2).20230117A.
2
Cardiopulmonary Exercise Test and Rehabilitation for Pulmonary Hypertension Patients.肺动脉高压患者的心肺运动试验与康复
Acta Cardiol Sin. 2022 Nov;38(6):663-666. doi: 10.6515/ACS.202211_38(6).20220603A.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
4
Future Perspectives of Pulmonary Hypertension Treatment.肺动脉高压治疗的未来展望
Acta Cardiol Sin. 2022 Jul;38(4):435-442. doi: 10.6515/ACS.202207_38(4).20220331A.
5
A Novel Variant Gene in Relation with Hereditary Pulmonary Arterial Hypertension Combined with Pulmonary Arteriovenous Malformations.一种与遗传性肺动脉高压合并肺动静脉畸形相关的新型变异基因。
Acta Cardiol Sin. 2022 Jul;38(4):542-545. doi: 10.6515/ACS.202207_38(4).20220210A.
6
Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.台湾中部遗传性和特发性肺动脉高压患者的全外显子组测序
Front Cardiovasc Med. 2022 Jun 22;9:911649. doi: 10.3389/fcvm.2022.911649. eCollection 2022.
7
Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.肺动脉高压的定期风险评估——隐匿性疾病进展的警示信号
Acta Cardiol Sin. 2022 Mar;38(2):113-123. doi: 10.6515/ACS.202203_38(2).20211005A.
8
Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients.中国汉族肺动脉高压患者的基因突变注释和家系分析。
Glob Heart. 2021 Oct 18;16(1):70. doi: 10.5334/gh.1002. eCollection 2021.
9
Pulmonary arterial hypertension in the elderly population.老年人群中的肺动脉高压
J Chin Med Assoc. 2022 Jan 1;85(1):18-23. doi: 10.1097/JCMA.0000000000000658.
10
Exercise Capacity and Quality of Life in Pulmonary Arterial Hypertension.肺动脉高压患者的运动能力与生活质量
Acta Cardiol Sin. 2021 Jan;37(1):74-85. doi: 10.6515/ACS.202101_37(1).20200720A.
Zotero 插件